Discontinued — last reported Q3 '19

Products & Services · Revenue

Hcs — Revenue

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ2 2018
Last reportedQ3 2019Nov 8, 2019
Rolls up toTotal Revenue

How to read this metric

An increase indicates growing demand for genetic carrier screening services and successful market penetration, while a decrease may signal increased competition or changes in insurance reimbursement policies for genetic testing.

Detailed definition

This metric represents the total revenue generated from the Horizon Carrier Screening (HCS) product line, excluding any...

Peer comparison

Comparable to revenue metrics for specialized diagnostic testing services or genetic screening segments at other life sciences and molecular diagnostics companies.

Metric ID: ntra_segment_hcs_revenue_from_contract_with_customer_excluding_assessed_tax

Similar Metrics at Other Companies

Guardant Health logo
Guardant HealthGHView metric
Illumina logo
IlluminaILMNView metric
Illumina logo
IlluminaILMNView metric
Zoetis logo
ZoetisZTSView metric
IonQ logo
IonQIONQView metric
Huntington Bancshares logo
Huntington BancsharesHBANView metric

Frequently Asked Questions

What does hcs — revenue mean?
The total revenue earned from the company's genetic carrier screening services.